-
Study aim
-
Determining the effect of topical magnesium sulfate on the cervix in the progression of labor : A clinical trial
-
Design
-
Two arm parallel group randomized trial with 100 pregnant women in each group, randomized with block randomization method
-
Settings and conduct
-
This study will be performed in labor ward , Kamali hospital, Karj on all women candidates for normal delivery who are eligible for the study. Patients who have consciously signed a consent form to participate in the project will be randomly assigned to two groups. The randomization list will be prepared by the statistician. Treatments will be placed in sealed envelopes and will be kept by the out-of-study nurse. After identification of the eligibility of the patient, the procedure will be explained to her and informed consent will be obtained. Completing the final information is the responsibility of the person who is unaware of the type of treatment. The statistician will also be kept blind
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Pregnant woman candidate for vaginal birth, primigravida gestational age>= 38 weeks; Non-inclusion criteria: Indications for cesarean section including failure to progress, cessation of labor, decreased heart rate, bleeding and cleft palate, placenta abruption, fever, and chorioamnionitis, underlying diseases such as diabetes and hypertension, Preeclampsia and eclampsiae
-
Intervention groups
-
Intervention group: They will received 5 cc magnesium sulfate 50%, topically on the cervix in the latent and active phase of labor.
Control group: They will received 5 cc normal saline, topically on the cervix in the latent and active phase of labor
-
Main outcome variables
-
Duration of labor, changes in Bishop score